Analysed PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) News Sources
PDS Biotechnology Corp (PDSB) Q4 2025 Earnings Call Highlights: Financial Discipline Amid ...
31-03-2026
yahoo.com
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
30-03-2026
yahoo.com
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
24-03-2026
yahoo.com
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
20-02-2026
yahoo.com
PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI
28-01-2026
yahoo.com
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
09-01-2026
yahoo.com
What is the current price of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)?
The current price of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) is $1.09.
PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) absolute price change since previous trading day?
The absolute price change of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) since the previous trading day is $0.01.
PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) percentage price change since previous trading day?
The percentage price change of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) since the previous trading day is 0.9259%.
What is the most recent average sentiment score for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)?
The most recent average sentiment score for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)?
The most recent sentiment for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) is .
SEC-8K** Filing Available For PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.